280 related articles for article (PubMed ID: 15472385)
1. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
[TBL] [Abstract][Full Text] [Related]
2. Long-term stability of a coronary stent coating post-implantation.
Lewis AL; Furze JD; Small S; Robertson JD; Higgins BJ; Taylor S; Ricci DR
J Biomed Mater Res; 2002; 63(6):699-705. PubMed ID: 12418013
[TBL] [Abstract][Full Text] [Related]
3. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
[TBL] [Abstract][Full Text] [Related]
4. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.
Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM
J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644
[TBL] [Abstract][Full Text] [Related]
6. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
7. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
Richard R; Schwarz M; Chan K; Teigen N; Boden M
J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
[TBL] [Abstract][Full Text] [Related]
9. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylcholine-coated stents.
Lewis AL; Stratford PW
J Long Term Eff Med Implants; 2002; 12(4):231-50. PubMed ID: 12627785
[TBL] [Abstract][Full Text] [Related]
11. Biomimicry 1: PC.
Cumberland DC; Gunn J; Malik N; Holt CM
Semin Interv Cardiol; 1998; 3(3-4):149-50. PubMed ID: 10406685
[TBL] [Abstract][Full Text] [Related]
12. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
[TBL] [Abstract][Full Text] [Related]
13. Coronary stents: a materials perspective.
Mani G; Feldman MD; Patel D; Agrawal CM
Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
[TBL] [Abstract][Full Text] [Related]
15. Programmable elution profile coating for drug eluting stents.
Al-Lamee K
Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
[TBL] [Abstract][Full Text] [Related]
17. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
[TBL] [Abstract][Full Text] [Related]
18. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
[TBL] [Abstract][Full Text] [Related]
19. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
[TBL] [Abstract][Full Text] [Related]
20. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
Steigerwald K; Merl S; Kastrati A; Wieczorek A; Vorpahl M; Mannhold R; Vogeser M; Hausleiter J; Joner M; Schömig A; Wessely R
Biomaterials; 2009 Feb; 30(4):632-7. PubMed ID: 18990438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
